Thompson Siegel & Walmsley LLC Merck & Co., Inc. Transaction History

Thompson Siegel & Walmsley LLC

$6.71 Billion
Q3 2024

A detailed history of Thompson Siegel & Walmsley LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Thompson Siegel & Walmsley LLC holds 248,087 shares of MRK stock, worth $24.3 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

248,087

Previous 249,170 0.43%

Holding current value

$24.3 Million

Previous $30.8 Million 8.67%

% of portfolio

0.42%

Previous 0.49%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$111.15 - $128.97 $120,375 - $139,674	-1,083 Reduced 0.43%	248,087 $28.2 Million
Q2 2024 Aug 08, 2024	SELL	$123.8 - $132.96 $172,701 - $185,479	-1,395 Reduced 0.56%	249,170 $30.8 Million
Q1 2024 May 09, 2024	SELL	$113.24 - $131.95 $440,277 - $513,021	-3,888 Reduced 1.53%	250,565 $33.1 Million
Q4 2023 Feb 07, 2024	SELL	$100.18 - $109.02 $540,671 - $588,380	-5,397 Reduced 2.08%	254,453 $27.7 Million
Q3 2023 Nov 08, 2023	BUY	$102.95 - $114.33 $55,695 - $61,852	541 Added 0.21%	259,850 $26.8 Million
Q2 2023 Aug 10, 2023	SELL	$108.61 - $118.38 $673,490 - $734,074	-6,201 Reduced 2.34%	259,309 $29.9 Million
Q1 2023 May 11, 2023	SELL	$102.94 - $114.86 $571,008 - $637,128	-5,547 Reduced 2.05%	265,510 $28.2 Million
Q4 2022 Feb 10, 2023	BUY	$87.44 - $112.11 $23.7 Million - $30.4 Million	271,057 New	271,057 $30.1 Million
Q3 2022 Oct 25, 2022	SELL	$84.53 - $94.96 $157,817 - $177,290	-1,867 Reduced 0.62%	298,461 $25.7 Million
Q2 2022 Jul 22, 2022	SELL	$83.49 - $94.64 $6.04 Million - $6.85 Million	-72,367 Reduced 19.42%	300,328 $27.4 Million
Q1 2022 Apr 26, 2022	BUY	$73.51 - $82.4 $3.38 Million - $3.79 Million	45,995 Added 14.08%	372,695 $30.6 Million
Q4 2021 Feb 09, 2022	BUY	$72.28 - $90.54 $269,098 - $337,080	3,723 Added 1.15%	326,700 $25 Million
Q3 2021 Nov 05, 2021	BUY	$71.68 - $78.83 $139,202 - $153,087	1,942 Added 0.6%	322,977 $24.3 Million
Q2 2021 Aug 09, 2021	BUY	$70.31 - $77.77 $1.16 Million - $1.29 Million	16,540 Added 5.43%	321,035 $25 Million
Q1 2021 May 07, 2021	BUY	$68.86 - $81.11 $5.27 Million - $6.21 Million	76,595 Added 33.61%	304,495 $23.5 Million
Q4 2020 Feb 08, 2021	BUY	$71.77 - $79.65 $1.47 Million - $1.63 Million	20,498 Added 9.88%	227,900 $18.6 Million
Q3 2020 Nov 12, 2020	BUY	$73.18 - $82.95 $1.77 Million - $2 Million	24,151 Added 13.18%	207,402 $17.2 Million
Q2 2020 Aug 11, 2020	BUY	$70.42 - $80.13 $3.66 Million - $4.17 Million	51,991 Added 39.61%	183,251 $14.2 Million
Q1 2020 May 12, 2020	BUY	$63.36 - $87.82 $256,798 - $355,934	4,053 Added 3.19%	131,260 $10.1 Million
Q4 2019 Feb 07, 2020	BUY	$77.58 - $87.54 $805,590 - $909,015	10,384 Added 8.89%	127,207 $11.6 Million
Q3 2019 Nov 12, 2019	SELL	$76.08 - $82.93 $94,034 - $102,501	-1,236 Reduced 1.05%	116,823 $9.83 Million
Q2 2019 Aug 12, 2019	BUY	$69.84 - $81.59 $7,752 - $9,056	111 Added 0.09%	118,059 $9.9 Million
Q1 2019 May 13, 2019	SELL	$69.58 - $79.36 $18,647 - $21,268	-268 Reduced 0.23%	117,948 $9.81 Million
Q4 2018 Feb 11, 2019	BUY	$65.24 - $75.71 $655,662 - $760,885	10,050 Added 9.29%	118,216 $9.03 Million
Q2 2018 Aug 09, 2018	BUY	$50.83 - $59.72 $334,969 - $393,554	6,590 Added 6.49%	108,166 $6.57 Million
Q1 2018 May 08, 2018	SELL	$50.96 - $59.23 $546,342 - $635,004	-10,721 Reduced 9.55%	101,576 $5.53 Million
Q4 2017 Feb 09, 2018	BUY	$51.62 - $61.64 $177,211 - $211,610	3,433 Added 3.15%	112,297 $6.32 Million
Q3 2017 Nov 08, 2017	BUY	$58.67 - $63.13 $118,044 - $127,017	2,012 Added 1.88%	108,864 $6.97 Million
Q2 2017 Aug 09, 2017	BUY	N/A	106,852	106,852 $6.85 Million

Others Institutions Holding MRK

# of Institutions

3,816

Shares Held

1.86B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.

Account

Thompson Siegel & Walmsley LLC Merck & Co., Inc. Transaction History